We are live on ! Find out more
TIL icon

Instil Bio

30 hedge funds and large institutions have $43.5M invested in Instil Bio in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.31% less ownership

Funds ownership: 65.35%65.04% (-0.31%)

3% less funds holding

Funds holding: 3130 (-1)

5% less capital invested

Capital invested by funds: $45.9M → $43.5M (-$2.37M)

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
30
Holders Change
-1
Holders Change %
-3.23%
% of All Funds
0.43%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
3
Increased
7
Reduced
8
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CVV
1
Curative Ventures V
Texas
$19.5M
VC
2
Vivo Capital
California
$6.42M +$11 +1 +0%
CI
3
CPMG Inc
Texas
$4.23M
BCM
4
BML Capital Management
Indiana
$4.02M +$458K +42,368 +12%
CCC
5
Cable Car Capital
California
$2.66M
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.33M -$2.54K -235 -0.2%
NCM
7
Nantahala Capital Management
Connecticut
$1.31M
Renaissance Technologies
8
Renaissance Technologies
New York
$1.2M -$108K -10,000 -8%
BlackRock
9
BlackRock
New York
$628K
Marshall Wace
10
Marshall Wace
United Kingdom
$624K
Geode Capital Management
11
Geode Capital Management
Massachusetts
$375K +$17.7K +1,641 +5%
Millennium Management
12
Millennium Management
New York
$325K +$2.7K +250 +0.8%
Two Sigma Advisers
13
Two Sigma Advisers
New York
$289K -$15.1K -1,400 -5%
Two Sigma Investments
14
Two Sigma Investments
New York
$245K -$223K -20,610 -46%
State Street
15
State Street
Massachusetts
$125K +$5.4K +500 +4%
Acadian Asset Management
16
Acadian Asset Management
Massachusetts
$104K
Morgan Stanley
17
Morgan Stanley
New York
$52K -$5.73K -530 -9%
Northwestern Mutual Wealth Management
18
Northwestern Mutual Wealth Management
Wisconsin
$6.43K +$6.75K +625 New
Jones Financial Companies
19
Jones Financial Companies
Missouri
$5.14K +$5.4K +500 New
Barclays
20
Barclays
United Kingdom
$4.93K
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
$2K +$1.85K +171 New
Citigroup
22
Citigroup
New York
$1.18K +$1.22K +113 +5,650%
RhumbLine Advisers
23
RhumbLine Advisers
Massachusetts
$1.17K
BNP Paribas Financial Markets
24
BNP Paribas Financial Markets
France
$1.09K -$778 -72 -40%
TRCT
25
Tower Research Capital (TRC)
New York
$731 -$2.19K -203 -74%

TIL Hedge Fund Activity: Q2 2024 in Review

30 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q2 2024, worth a combined $43.5M — down 5.2% from $45.9M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of TIL and 3 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 7 added.

The largest buyer was BML Capital Management, adding an estimated $458K. The largest seller was Two Sigma Investments, cutting an estimated $223K.

  • 30 institutional investors held Instil Bio (TIL) as of Q2 2024, down from 31 in Q1 2024.
  • Funds reported $43.5M of Instil Bio stock for Q2 2024, down 5.2% quarter-over-quarter.
  • 3 funds opened new Instil Bio positions in Q2 2024 and 4 closed out, a net change of -1 holder.
  • The largest Instil Bio buyer in Q2 2024 was BML Capital Management, an estimated $458K added.
  • The largest Instil Bio seller in Q2 2024 was Two Sigma Investments, an estimated $223K sold.

Based on aggregated 13F filings for Q2 2024.